145 related articles for article (PubMed ID: 36946452)
1. Cross-Sectional and Longitudinal Comparison of Tau Imaging with 18F-MK6240 and 18F-Flortaucipir in Populations Matched for Age, MMSE and Brain Beta-Amyloid Burden.
Bourgeat P; Krishnadas N; Doré V; Mulligan R; Tyrrell R; Bozinovski S; Huang K; Fripp J; Villemagne VL; Rowe CC
J Prev Alzheimers Dis; 2023; 10(2):251-258. PubMed ID: 36946452
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.
Ossenkoppele R; Smith R; Mattsson-Carlgren N; Groot C; Leuzy A; Strandberg O; Palmqvist S; Olsson T; Jögi J; Stormrud E; Cho H; Ryu YH; Choi JY; Boxer AL; Gorno-Tempini ML; Miller BL; Soleimani-Meigooni D; Iaccarino L; La Joie R; Baker S; Borroni E; Klein G; Pontecorvo MJ; Devous MD; Jagust WJ; Lyoo CH; Rabinovici GD; Hansson O
JAMA Neurol; 2021 Aug; 78(8):961-971. PubMed ID: 34180956
[TBL] [Abstract][Full Text] [Related]
3. Association of Initial β-Amyloid Levels With Subsequent Flortaucipir Positron Emission Tomography Changes in Persons Without Cognitive Impairment.
Knopman DS; Lundt ES; Therneau TM; Albertson SM; Gunter JL; Senjem ML; Schwarz CG; Mielke MM; Machulda MM; Boeve BF; Jones DT; Graff-Radford J; Vemuri P; Kantarci K; Lowe VJ; Petersen RC; Jack CR;
JAMA Neurol; 2021 Feb; 78(2):217-228. PubMed ID: 33074304
[TBL] [Abstract][Full Text] [Related]
4. Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease.
Leuzy A; Smith R; Cullen NC; Strandberg O; Vogel JW; Binette AP; Borroni E; Janelidze S; Ohlsson T; Jögi J; Ossenkoppele R; Palmqvist S; Mattsson-Carlgren N; Klein G; Stomrud E; Hansson O
JAMA Neurol; 2022 Feb; 79(2):149-158. PubMed ID: 34928318
[TBL] [Abstract][Full Text] [Related]
5. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Group-Level and Individualized Brain Regions for Measuring Change in Longitudinal Tau Positron Emission Tomography in Alzheimer Disease.
Leuzy A; Binette AP; Vogel JW; Klein G; Borroni E; Tonietto M; Strandberg O; Mattsson-Carlgren N; Palmqvist S; Pontecorvo MJ; Iaccarino L; Stomrud E; Ossenkoppele R; Smith R; Hansson O;
JAMA Neurol; 2023 Jun; 80(6):614-623. PubMed ID: 37155176
[TBL] [Abstract][Full Text] [Related]
7. Rates of regional tau accumulation in ageing and across the Alzheimer's disease continuum: an AIBL
Krishnadas N; Doré V; Robertson JS; Ward L; Fowler C; Masters CL; Bourgeat P; Fripp J; Villemagne VL; Rowe CC
EBioMedicine; 2023 Feb; 88():104450. PubMed ID: 36709581
[TBL] [Abstract][Full Text] [Related]
8. Two-Year Prognostic Utility of Plasma p217+tau across the Alzheimer's Continuum.
Feizpour A; Doré V; Doecke JD; Saad ZS; Triana-Baltzer G; Slemmon R; Maruff P; Krishnadas N; Bourgeat P; Huang K; Fowler C; Rainey-Smith SR; Bush AI; Ward L; Robertson J; Martins RN; Masters CL; Villemagne VL; Fripp J; Kolb HC; Rowe CC
J Prev Alzheimers Dis; 2023; 10(4):828-836. PubMed ID: 37874105
[TBL] [Abstract][Full Text] [Related]
9. A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementia.
Pontecorvo MJ; Devous MD; Kennedy I; Navitsky M; Lu M; Galante N; Salloway S; Doraiswamy PM; Southekal S; Arora AK; McGeehan A; Lim NC; Xiong H; Truocchio SP; Joshi AD; Shcherbinin S; Teske B; Fleisher AS; Mintun MA
Brain; 2019 Jun; 142(6):1723-1735. PubMed ID: 31009046
[TBL] [Abstract][Full Text] [Related]
10. The Association of Age-Related and Off-Target Retention with Longitudinal Quantification of [
Tissot C; Servaes S; Lussier FZ; Ferrari-Souza JP; Therriault J; Ferreira PCL; Bezgin G; Bellaver B; Leffa DT; Mathotaarachchi SS; Chamoun M; Stevenson J; Rahmouni N; Kang MS; Pallen V; Margherita-Poltronetti N; Wang YT; Fernandez-Arias J; Benedet AL; Zimmer ER; Soucy JP; Tudorascu DL; Cohen AD; Sharp M; Gauthier S; Massarweh G; Lopresti B; Klunk WE; Baker SL; Villemagne VL; Rosa-Neto P; Pascoal TA
J Nucl Med; 2023 Mar; 64(3):452-459. PubMed ID: 36396455
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages.
Pascoal TA; Benedet AL; Tudorascu DL; Therriault J; Mathotaarachchi S; Savard M; Lussier FZ; Tissot C; Chamoun M; Kang MS; Stevenson J; Massarweh G; Guiot MC; Soucy JP; Gauthier S; Rosa-Neto P
Brain; 2021 Dec; 144(11):3517-3528. PubMed ID: 34515754
[TBL] [Abstract][Full Text] [Related]
12. Influence of common reference regions on regional tau patterns in cross-sectional and longitudinal [
Young CB; Landau SM; Harrison TM; Poston KL; Mormino EC;
Neuroimage; 2021 Nov; 243():118553. PubMed ID: 34487825
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders.
Leuzy A; Smith R; Ossenkoppele R; Santillo A; Borroni E; Klein G; Ohlsson T; Jögi J; Palmqvist S; Mattsson-Carlgren N; Strandberg O; Stomrud E; Hansson O
JAMA Neurol; 2020 Aug; 77(8):955-965. PubMed ID: 32391858
[TBL] [Abstract][Full Text] [Related]
14. Mesial temporal tau in amyloid-β-negative cognitively normal older persons.
Krishnadas N; Doré V; Groot C; Lamb F; Bourgeat P; Burnham SC; Huang K; Goh AMY; Masters CL; Villemagne VL; Rowe CC;
Alzheimers Res Ther; 2022 Apr; 14(1):51. PubMed ID: 35395950
[TBL] [Abstract][Full Text] [Related]
15. Initial levels of β-amyloid and tau deposition have distinct effects on longitudinal tau accumulation in Alzheimer's disease.
Cai Y; Du J; Li A; Zhu Y; Xu L; Sun K; Ma S; Guo T;
Alzheimers Res Ther; 2023 Feb; 15(1):30. PubMed ID: 36750884
[TBL] [Abstract][Full Text] [Related]
16. Partial volume correction in longitudinal tau PET studies: is it really needed?
Costoya-Sánchez A; Moscoso A; Sobrino T; Ruibal Á; Grothe MJ; Schöll M; Silva-Rodríguez J; Aguiar P;
Neuroimage; 2024 Apr; 289():120537. PubMed ID: 38367651
[TBL] [Abstract][Full Text] [Related]
17. Association of Apolipoprotein E ε4 With Medial Temporal Tau Independent of Amyloid-β.
Therriault J; Benedet AL; Pascoal TA; Mathotaarachchi S; Chamoun M; Savard M; Thomas E; Kang MS; Lussier F; Tissot C; Parsons M; Qureshi MNI; Vitali P; Massarweh G; Soucy JP; Rej S; Saha-Chaudhuri P; Gauthier S; Rosa-Neto P
JAMA Neurol; 2020 Apr; 77(4):470-479. PubMed ID: 31860000
[TBL] [Abstract][Full Text] [Related]
18. 18F-Flortaucipir PET Associations with Cerebrospinal Fluid, Cognition, and Neuroimaging in Mild Cognitive Impairment due to Alzheimer's Disease.
Okafor M; Nye JA; Shokouhi M; Shaw LM; Goldstein F; Hajjar I
J Alzheimers Dis; 2020; 74(2):589-601. PubMed ID: 32065800
[TBL] [Abstract][Full Text] [Related]
19. A multicenter comparison of [
Leuzy A; Pascoal TA; Strandberg O; Insel P; Smith R; Mattsson-Carlgren N; Benedet AL; Cho H; Lyoo CH; La Joie R; Rabinovici GD; Ossenkoppele R; Rosa-Neto P; Hansson O
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(7):2295-2305. PubMed ID: 34041562
[TBL] [Abstract][Full Text] [Related]
20. Optimizing quantification of MK6240 tau PET in unimpaired older adults.
Harrison TM; Ward TJ; Murphy A; Baker SL; Dominguez PA; Koeppe R; Vemuri P; Lockhart SN; Jung Y; Harvey DJ; Lovato L; Toga AW; Masdeu J; Oh H; Gitelman DR; Aggarwal N; Snyder HM; Baker LD; DeCarli C; Jagust WJ; Landau SM;
Neuroimage; 2023 Jan; 265():119761. PubMed ID: 36455762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
